Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies
Antigen-binding fragments of antibodies specific to the tumor-associated ganglioside GD2 are well poised to play a substantial role in modern GD2-targeted cancer therapies, however, rapid elimination from the body and reduced affinity compared to full-length antibodies limit their therapeutic potent...
Main Authors: | Irina V. Kholodenko, Daniel V. Kalinovsky, Elena V. Svirshchevskaya, Igor I. Doronin, Maria V. Konovalova, Alexey V. Kibardin, Tatyana V. Shamanskaya, Sergey S. Larin, Sergey M. Deyev, Roman V. Kholodenko |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/21/3835 |
Similar Items
-
Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment–Drug Conjugates Carrying Maytansinoids DM1 and DM4
by: Daniel V. Kalinovsky, et al.
Published: (2023-10-01) -
RNA Sequencing-Based Identification of Ganglioside GD2-Positive Cancer Phenotype
by: Maxim Sorokin, et al.
Published: (2020-05-01) -
Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors
by: Daniel V Kalinovsky, et al.
Published: (2022-06-01) -
Molecular basis for multimerization in the activation of the epidermal growth factor receptor
by: Yongjian Huang, et al.
Published: (2016-03-01) -
The biological role and immunotherapy of gangliosides and GD3 synthase in cancers
by: Shangqi Cao, et al.
Published: (2023-02-01)